Skip to main content
. Author manuscript; available in PMC: 2024 Sep 22.
Published in final edited form as: Oral Oncol. 2021 Dec 27;125:105675. doi: 10.1016/j.oraloncology.2021.105675

Fig. 1.

Fig. 1.

Kaplan-Meier of OS and DSS for metastatic head and neck cancer of pharynx patients. (A) OS based on HPV status in mHNSC-P patients. (B) DSS based on HPV status in mHNSC-P patients. aHR means Hazard ratio of HPV-positive vs. HPV-negative patients by adjusting for age, race, gender, grade, T stage, N stage and treatment. 95 %CI means the range of estimates with 95% confidence intervals.